Biopharmaceutical companies face an increasingly complex environment. Business imperatives for stronger drug development pipelines and improved operational efficiency are driving innovation and technology within the IT sector. Additionally, new genomics technologies as well as other high-throughput technologies present enormous informational, strategic and organizational challenges. How biopharm companies embrace these new technologies could make a crucial difference in their success and well-being.
